Latest Reports

Companion Diagnostics and Biomarker Development (PH169)

Harness companion diagnostic metrics to set strategy, improve partner selection and build a program of targeted therapy development.

 
Strategic Medical Publications Management (PH163)

Demonstrate medical publications' value, boost investment and meet diverse stakeholder needs for clinical and scientific information.

 
Pharmaceutical Portfolio Management (PH162)

Master portfolio management and drive coordinated execution using benchmarks and best practices from pre-clinical to end of life.

 
Pharmaceutical Digital Marketing and Social Media (PH161)

Build digital marketing capabilities while navigating the challenging regulatory environment.

 
Health Outcomes Liaisons (PH159)

Develop HOL capabilities and reach payers via optimal team alignment and structure, competitive compensation and a strong slate of core HOL activities.

 
Succession Planning (FL56)

Build, implement and improve your company’s succession plan using real-company metrics, case studies and sample plans. 

 
Investigator Initiated Trial Management (PH158)

Develop a cohesive IIT strategy, reap study benefits, and streamline proposal review and ongoing oversight.

 
Market Access Management (PH160)

Assemble an elite market access team and improve global strategy while exploring resource benchmarks and relevant trends.

 
Phase IV Clinical Trials (PH157)

Improve Phase IV strategy and execution with strong leadership and benchmarks for budgets, staffing, trial timelines and more.

 
Business Development and Licensing (PH154)

Reinforce business development and licensing capabilities to capitalize on deal opportunities, drive successful negotiations and foster lucrative pharmaceutical and biotechnology partnerships.